CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies

CAR-based immunotherapy for breast cancer: peculiarities, ongoing investigations, and future strategies

Surgery, chemotherapy, and endocrine therapy have improved the overall survival and postoperative recurrence rates of Luminal A, Luminal B, and HER2-positive breast cancers but treatment modalities for triple-negative breast cancer (TNBC) with poor prognosis remain limited. The effective application...

Full description

Bibliographic Details
Main Authors: Zhipu Niu, Jingyuan Wu, Qiancheng Zhao, Jinyu Zhang, Pengyu Zhang, Yiming Yang
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-04-01
Series:Frontiers in Immunology
Subjects:
breast cancer
CAR-T
CAR-NK
CAR-M
exosome
TME
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1385571/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2024.1385571/full

Similar Items